1. American Diabetes Association. Diabetes Statistics. Alexandria, VA: American Diabetes Association, 2006.
2. American Diabetes Association. Medical Management of Type 2 Diabetes. Alexandria, VA: American Diabetes Association, 1998.
3. Diabetes Research Working Group. Congressional report on National Institutes of Health implementation of the recommendations of the Congressionally-directed Diabetes Research Working Group, 1998.
4. Mokdad AH, Ford ES. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 2000; 23:1278-83.
5. Ogden CL, Carroll MD. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295:1549-55.
6. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723-7.
8. Nestle M, Jacobson MF. Halting the obesity epidemic: a public health policy approach. Public Health Rep 2000; 115:12-24.
9. Federation of American Societies for Experimental Biology, LSRO. Executive summary from the third report on nutrition monitoring in the United States. J Nutr 1996; 126:1907S-36.
10. Schumann M. Megabrands: top brands hold the line in 2001. Advertising Age 2002; S1-9:200-12.
11. USDA. 1994-96 Continuing survey of food intakes by individuals. USDA 2002:10-7.
12. Battle EK, Brownell KD. Confronting a rising tide of eating disorders and obesity: treatment vs. prevention and policy. Addict Behav 1996; 21:755-65.
13. Burros M. Losing count of calories as plates fill up. New York Times 2 April 1997; Section C:4.
14. Bar-Or O, Foreyt J. Physical activity, genetic, and nutritional considerations in childhood weight management. Med Sci Sports Exerc 1998; 30:2-10.
15. USDA. Data tables: Results from USDAs 1994-96. Continuing Survey of Food Intakes by Individuals and 1994-96 Diet and Health Knowledge Survey. USDA 1997.
16. World Health Organization. Obesity: preventing and managing a global epidemic. Report of a WHO Consultation. 2000. Geneva, WHO: WHO Technical Report Series 894. 1999.
17. Tufts University. Special Report: Portion Distortion. Tufts University Health & Nutrition Newsletter 2002; 18:4-5.
18. Center for Disease Control. Trends in intake of energy and macronutrients—United States, 1971-2000. CDC 2004; 11-8-2006.
19. Wylie-Rosett J, Herman WH, Goldberg RB. Lifestyle intervention to prevent diabetes: intensive and cost effective. Curr Opin Lipidol 2006; 17:37-44.
20. Pan XR, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20:537-44.
21. Tuomilehto J, Lindstrom J. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343-50.
22. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:403.
23. Hamman RF, Wing RR. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006; 29:2102-7.
24. Bradley C. Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. London: Harwood Academic Publishers, 1994.
25. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15:205-18.
26. Snoek FJ, Skinner TC. Psychology in Diabetes Care. New York: John Wiley & Sons, 2000.
27. Glasgow RE, Hiss RG. Report of the health care delivery work group: behavioral research related to the establishment of a chronic disease model for diabetes care. Diabetes Care 2001; 24:124-30.
28. Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. J Clin Psychol 2001; 57:457-78.
29. Jacobson AM. The psychological care of patients with insulin-dependent diabetes mellitus. N Engl J Med 1996; 334:1249-53.
30. Rubin RR. Counselling and Psychotherapy in Diabetes Mellitus. In: Snoek FJ, Skinner TJ, eds. Psychology in Diabetes Care. New York, NY: Wiley, 2000:235-63.
31. Funnell MF, Anderson RM. Patient Empowerment. In: Snoek FJ, ST eds. Psychology in Diabetes Care. New York: Wiley, 2000.
32. Polonsky WH. Diabetes burnout. What to do when you can't take it anymore. Alexandria, VA: American Diabetes Association, 2000.
33. Day JL. Diabetic patient education: determinants of success. Diabetes Metab Res Rev 2000; 16 (Suppl. 1):S70-4.
34. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17:267-74.
35. Glasgow RE. Medical Office-Based Interventions. In: Snoek FJ, Skinner TC, eds. Psychology in Diabetes Care. New York, NY: Wiley, 2000:141-68.
36. Clark M, Asimakopoulou K. Diabetes in Older Adults. In: Snoek FJ, Skinner TC, eds. Psychology in Diabetes Care. New York, NY: Wiley, 2000.
37. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications with type 2 diabetes (UKPDS). Lancet 1998; 352:837-53.
38. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care 1998; 20:760-6.
39. Snoek FJ, Pouwer F, Welch GW, Polonsky WH. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care 2000; 23:1305-9.
40. Welch GW, de Groot M, Buckland GT, Chipkin S. Risk stratification of diabetes patients using diet barriers and self care motivation in an inner city hospital setting. Diabetes 1999; 48(Suppl).
41. Polonsky WH, Anderson BJ. Assessment of diabetes-related emotional distress. Diabetes Care 1995; 18:754-60.
42. Peyrot M, Rubin RR. Psychosocial problems and barriers to improved diabetes management: results of the cross-national diabetes attitudes, wishes and needs (DAWN) Study. Diabet Med 2005; 22:1379-85.
43. Delamater AM, Cox DJ. Psychological stress, coping, and diabetes. Diabetes Spect 1994; 7:46-9.
44. Surwit RS, Schneider MS. Role of stress in the etiology and treatment of diabetes mellitus. Psychosom Med 1993; 55:380-93.
45. Surwit RS, Schneider MS, Feinglos MN. Stress and diabetes mellitus. Diabetes Care 1992; 15:1413-22.
46. Peyrot MF, McMurry JF Jr. Stress buffering and glycemic control. The role of coping styles. Diabetes Care 1992; 15:842-6.
47. Aikens JE, Kiolbasa TA, Sobel R. Psychological predictors of glycemic change with relaxation training in non-insulin-dependent diabetes mellitus. Psychother. Psychosom 1997; 66:302-6.
48. Cohen ST, Welch G, Jacobson AM, de Groot M, Samson J. The association of lifetime psychiatric illness and increased retinopathy in patients with type I diabetes mellitus. Psychosomatics 1997; 38: 98-108.
49. Crow S, Kendall D, Praus B, Thuras P. Binge eating and other psychopathology in patients with type 2 diabetes mellitus. Int J Eat Dis 2001; 30:222-6.
50. Pouwer F, Beekman AT. Rates and risks for co-morbid depression in patients with type 2 diabetes mellitus: results from a community-based study. Diabetologia 2003; 46:892-98.
51. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24:1069-78.
Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988; 145:976-81.
Lustman PJ, Griffith LS. Effects of nortriptyline on depression and glycemic control in diabetes:
results of a double-blind, placebo-controlled trial. Psychosom Med 1997; 59:241-50.
Mazze RS, Lucido D, Shamoon H. Psychological and social correlates of glycemic control. Diabetes
de Groot M, Jacobson AM, Samson JA, Welch G. Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res 1984; 46:425-35. Lustman PJ, Griffith LS, Freedland KE, Clouse RE. The course of major depression in diabetes. Gen Hosp Psychiatry 1997; 19:138-43.
Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 1998; 129:613-21. Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999; 22:1071-6.
Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19:1097-102.
Arroyo C, Hu FB. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004; 27:129-33.
Golden SH, Williams JE. Depressive symptoms and the risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care 2004; 27:429-35.
Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000; 23:618-23. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63:619-30.
Kroenke K. Discovering depression in medical patients: reasonable expectations. Ann Intern Med 1997; 126:463-5.
Williams JW Jr, Mulrow CD. Case-finding for depression in primary care: a randomized trial. Am J Med 1999; 106:36-43.
De Groot M, Jacobson AM, Samson JA. Psychiatric illness in patients with type 1 and type 2 diabetes mellitus. Psychosom Med 1994; 56:176A.
Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997; 20:585-90.
Green L, Feher M, Catalan J. Fears and phobias in people with diabetes. Diabetes Metab Res Rev 2000; 16:287-93.
Surwit RS, van Tilburg MA. Stress management improves long-term glycemic control in type 2 diabetes. Diabetes Care 2002; 25:30-4.
Yoo JS, Kim EJ, Lee SJ. The effects of a comprehensive life style modification program on glycemic control and stress response in type 2 diabetes. Taehan Kanho Hakhoe Chi 2006; 36:751-60. Okada S, Ichiki K. Effect of an anxiolytic on lipid profile in non-insulin-dependent diabetes mellitus. J Int Med Res 1994; 22:338-42.
Lustman PJ, Griffith LS. Effects of alprazolam on glucose regulation in diabetes. Results of doubleblind, placebo-controlled trial. Diabetes Care 1995; 18:1133-9.
Svacina S. Our experience with antidepressant treatment in the obese and type 2 diabetics. Prague Med Rep 2005; 106:291-6.
Cox D, Gonder-Frederick L. A multicenter evaluation of blood glucose awareness training-II. Diabetes Care 1995; 18:523-8.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 1994.
Stinson FS, Grant BF. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2005; 80:105-16.
McQuade WH, Levy SM, Yanek LR, Davis SW, Liepman MR. Detecting symptoms of alcohol abuse in primary care settings. Arch Fam Med 2000; 9:814-21.
Avogaro A, Tiengo A. Alcohol, glucose metabolism and diabetes. Diabetes Metab Rev 1993; 9: 129-46.
National Institute on Alcohol Abuse and Alcoholism. Eighth Special Report to the U.S. Congress on Alcohol and Health. Washington, DC: Secretary of Health and Human Services, 1993. Emanuele NV, Swade TF, Emanuele MA. Consequences of alcohol use in diabetics. Alcohol Health Res World 1998; 22:211-9.
Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252:1905-7.
National Institute of Mental Health. Eating disorders: facts about eating disorders and the search for solutions. NIH Publication No. P01 4901 2001.
Papelbaum M, Appolinario JC. Prevalence of eating disorders and psychiatric comorbidity in a clinical sample of type 2 diabetes mellitus patients. Rev Bras Psiquiatr 2005; 27:135-8.
84. Wing RR, Nowalk MP, Marcus MD, Koeske R, Finegold D. Subclinical eating disorders and glycemic control in adolescents with type I diabetes. Diabetes Care 1986; 9:162-7.
86. Kaplan RM, Sallis JF, Patterson TL. Health and Human Behavior. New York: McGraw-Hill, 1993.
87. House JS, ed. Work Stress and Social Support. Reading, MA: Addison-Wesley, 1981:13-40.
88. Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York: Springer, 1984.
89. Kawachi I, Colditz G. A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health 1996; 50:245-51.
90. Weissberg-Benchell J, Pichert JW. Counseling techniques for clinicians and educators. Diabetes Spect 1999; 12(2):103-7.
91. Boehm S, Schlenk EA, Funnell MM, Powers H, Ronis DL. Predictors of adherence to nutrition recommendations in people with non-insulin-dependent diabetes mellitus. Diabetes Educ 1997; 23: 157-65.
92. Hakim LS, Goldstein I. Diabetic sexual dysfunction. Endocrinol Metab Clin North Am 1996; 25: 379-400.
93. Chu NV, Edelman SV. Erectile dysfunction and diabetes. Curr Diab Rep 2002; 2:60-6.
94. Israilov S, Shmuely J. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 2005; 17:431-6.
96. Schreiner-Engel P, Schiavi RC, Vietorisz D, Smith H. The differential impact of diabetes type on female sexuality. J Psychosom Res 1987; 31:23-33.
97. Veves A, Webster L, Chen TF, Payne S, Boulton AJ. Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. Diabet Med 1995; 12:77-82.
98. Guay AT. Safety and tolerability of sildenafil citrate for the treatment of erectile function in men with type 1 and type 2 diabetes [abstract]. Diabetes 2000; 49(Suppl. l):363.
99. Boulton AJ, Selam JL, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia 2001; 44:1296-301.
100. Blonde L. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials. Curr Med Res Opin 2006; 22:2111-20.
101. Kent S. Is diabetes a form of accelerated aging? Geriatrics 1976; 31:140-54.
102. Perlmuter LC, Hakami MK. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 1984; 77:1043-8.
103. Strachan MWJ, Deary IJ, Ewing FME, Frier BM. Is type 2 (non-insulin dependent) diabetes mellitus associated with an increased risk of cognitive dysfunction? Diabetes Care 1997; 20:438-45.
104. Ryan CM, Greckle M. Why is learning and memory dysfunction in type 2 diabetes limited to older adults. Diabetes Metab Res Rev 2000; 16:308-15.
105. Debling D, Amelang M, Hasselbach P, Sturmer T. Diabetes and cognitive function in a population-based study of elderly women and men. J Diabetes Complications 2006; 20:238-45.
106. Manschot SM, Brands AM. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006; 55:1106-13.
107. Akisaki T, Sakurai T. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006; 22:376-84.
108. Steen E, Terry BM. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease—is this type 3 diabetes? J Alzheimers Dis 2005; 7:63-80.
109. Biessels GJ, Kappelle LJ. Increased risk of Alzheimer's disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 2005; 33:1041-4.
110. Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J Gerontol A Biol Sci Med Sci 2004; 59:178-83.
111. Craft S. Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 2005; 26(Suppl 1):65-9.
112. Sun MK, Alkon DL. Links between Alzheimer's disease and diabetes. Timely. top. Med Cardiovasc Dis 2006; 10:E24.
113. Marcus AO. Safety of drugs commonly used to treat hypertension, dyslipidemia, and type 2 diabetes (the metabolic syndrome): Part 1. Diabetes Technol Ther 2000; 2:101-10.
114. Frier BM. Hypoglycaemia and cognitive function in diabetes. Int J Clin Pract 2001; (Suppl):30-7.
Was this article helpful?
Here's How You Could End Anxiety and Panic Attacks For Good Prevent Anxiety in Your Golden Years Without Harmful Prescription Drugs. If You Give Me 15 minutes, I Will Show You a Breakthrough That Will Change The Way You Think About Anxiety and Panic Attacks Forever! If you are still suffering because your doctor can't help you, here's some great news...!